Papillary glioneural tumor presenting with multiple ischemic strokes: an aggressive presentation of a “benign” entity
Keywords:Papillary glioneural tumor, Ischemic infarct, Paraneoplastic syndrome
Papillary glioneural tumors are infrequent neoplasms of the central nervous system, classically presenting with an indolent clinical course, rarely being related to an aggressive presentation, and not being associated with ischemic or another type of paraneoplastic phenomena. We describe the first case of this type of presentation with a literature review of the current knowledge of this entity. A 16-year-old female presented with a hemorrhagic intra-axial lesion, confirmed to be a papillary glioneural tumor in the histopathological analysis, being associated with multiple ischemic cerebral and posterior fossa strokes without another discernable cause than the presence of a paraneoplastic syndrome, not previously reported with this type of neoplasms. A literature review is presented detailing the current knowledge about this entity and emphasizing the need for greater knowledge about its natural history, immunobiology and treatment alternatives, opening a new window for the study of this pathology and establishing the need for a strict follow-up of patients who have this kind of tumors in order to learn more about their evolution. The papillary glioneural tumor, a rare entity having generally with a benign course, can have different presentations. Greater knowledge is needed to understand this behavior in order to optimize patient’s outcomes.
Carangel B, Arrigucci U. Papillary glioneuronal tumor: case report and review of literature. G Chir. 2015;36(2):63-9.
Goethe E. Recurrent papillary glioneural tumor. World neurosurgery. 2019;128:127-30.
Komori T. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol. 1998;22(10):1171-83.
Li D. Clinical, radiological, and pathological features of 16 papillary glioneuronal tumors. Acta Neurochir (Wien). 2014;156(4):627-39.
Adam C. Papillary glioneural Tumor: Not always a benign tumor?. Clinical neuropathology. 2007;26(3):119-24.
Yadav N. Papillary glioneuronal tumors: A radiopathologic correlation. European Journal of Radiology. 2017;97(2017):44-52.
Doxtader E. Cytopathologic features of papillary glioneuronal tumor. Diagnostic Cytopathology. 2017;1-3.
Gelpi E. Papillary glioneuronal tumor. Neuropathology. 2007;27:468-73.
Demetriades AK. Papillary glioneuronal tumour: a review of the literature with two illustrative cases. Br J Neurosurg. 2013;27(3):401-4.
Schlamann A. An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle PLoS ONE. 2014;9(7):e101211.
Dalmau J. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7(4):327-40.
Myung JK, Byeon SJ, Kim B, Suh J, Kim SK, Park CK, et al. Papillary glioneuronal tumors: a review of clinicopathologic and molecular genetic studies. Am J Surg Pathol. 2011;35(12):1794-805.
Rocka S, Neverauskiene L, Nelson EL, Burneikiene S. Papillary Glioneuronal Tumour: A Case Report. Cureus. 2019;11(3):e4215.
Singh V, Gupta K, Salunke P, Kumar S, Radotra BD, Vasishta RK. Rosette-forming and papillary glioneuronal tumors - A clinicopathological and molecular analysis. Clin Neuropathol. 2019;38(4):180-8.
Matsumura N, Yokoo H, Mao Y, Yin W, Nakazato Y. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell? Neuropathology. 2013;33(3):246-55